A case of hypocomplementemic urticarial vasculitis syndrome successfully treated with omalizumab
Nucera E, Basta F, Buonomo A, Mezzacappa S, Margiotta D, Antonelli Incalzi R, Schiavino D
J Investig Allergol Clin Immunol · 2017
Key Findings
- ●First report of successful omalizumab treatment for HUVS
- ●Improvement in urticarial symptoms with anti-IgE therapy
Referenced in (1 disease)
Validation history
Full log →No validation events recorded yet. Source will be checked on the next kipine-source-validator run.
ID: pmid-29199964PMID: 29199964